ACTUALITÉS
I2MC

LiMitAging team’s work in La Dépêche

Un article de la Dépêche du Midi évoque les travaux de l’équipe LiMitAging menés par Souad Najib sur les bénéfices cardiovasculaires du jeûne intermittent. Cet article fait référence à la récente parution des résultats de cette étude dans la revue Cells : “Intermittent Fasting Resolves Dyslipidemia and Atherogenesis in Apolipoprotein E-Deficient Mice in a Diet-Dependent Manner, Irrespective of Sex

DDM FREDERIC CHARMEUX – RANGUEIL / INSTITUT DES MALADIES METABOLIQUES ET CARDIOVASCULAIRES / ETUDE SUR LE JEUNE ( JEÛNE ) INTERMITTENT / JULES MERIAN , SOUAD NAJID , LAURENT MARTINEZ /

Auteurs : Mérian, J.; Ghezali, L.; Trenteseaux, C.; Duparc, T.; Beuzelin, D.; Bouguetoch, V.; Combes, G.; Sioufi, N.; Martinez, L.O.; Najib, S

Abstract
In humans and animal models, intermittent fasting (IF) interventions promote body weight loss, improve metabolic health, and are thought to lower cardiovascular disease risk. However, there is a paucity of reports on the relevance of such nutritional interventions in the context of dyslipidemia and atherosclerotic cardiovascular diseases. The present study assessed the metabolic and atheroprotective effects of intermittent fasting intervention (IF) in atherosclerosis-prone apolipoprotein E-deficient (Apoe-/-) mice. Groups of male and female Apoe-/- mice were fed a regular (chow) or atherogenic (high-fat, high-cholesterol, HFCD) diet for 4 months, either ad libitum or in an alternate-day fasting manner. The results show that IF intervention improved glucose and lipid metabolism independently of sex. However, IF only decreased body weight gain in males fed chow diet and differentially modulated adipose tissue parameters and liver steatosis in a diet composition-dependent manner. Finally, IF prevented spontaneous aortic atherosclerotic lesion formation in mice fed chow diet, irrespective of sex, but failed to reduce HFCD-diet-induced atherosclerosis. Overall, the current work indicates that IF interventions can efficiently improve glucose homeostasis and treat atherogenic dyslipidemia, but a degree of caution is warranted with regard to the individual sex and the composition of the dietary regimen.

Keywords:intermittent fasting; glucose tolerance; hepatic steatosis; adipose tissue; reverse cholesterol transport; atherosclerosis
Cells 2023, 12(4), 533; https://doi.org/10.3390/cells12040533
logotype i2mc
logotype i2mc

Inserm/UPS UMR 1297 - I2MC Institut des Maladies Métaboliques et Cardiovasculaires

1 avenue Jean Poulhès - BP 84225 - 31432 Toulouse Cedex 4

Tél. : 05 61 32 56 00

Contactez-nous

 

Horaires

Du lundi au vendredi
8h30 - 12h30 / 13h45 -16h45